MMP-3 Mediates Psychosine-Induced Globoid Cell Formation: Implications for Leukodystrophy Pathology

作者: Kumiko Ijichi , Graham D. Brown , Craig S. Moore , Jean-Pyo Lee , Paige N. Winokur

DOI: 10.1002/GLIA.22471

关键词:

摘要: Globoid cell leukodystrophy (GLD) or Krabbe disease, is a fatal demyelinating disease attributed to mutations in the galactocerebrosidase (GALC) gene. Loss of function GALC result accumulation glycolipid intermediate, galactosylsphingosine (psychosine). Due cytotoxicity psychosine, it has been hypothesized that accumulated psychosine underlie pathophysiology GLD. However, cellular mechanisms GLD remain unclear. cells, multinucleated microglia/macrophages central nervous system (CNS), are defining characteristic Here we report exposure primary glial cultures induces expression and production matrix metalloproteinase (MMP)-3 mediated morphological transformation microglia into globoid type. Additionally, psychosine-induced formation from was prevented by either genetic ablation chemical inhibition MMP-3. These effects microglia-specific as peripheral macrophages exposed did not become activated express increased levels In brain twitcher mice, murine model human GLD, elevated MMP-3 relative wild-type littermates contemporaneous with onset further progression. Further, bone marrow transplantation (BMT), currently only therapeutically beneficial treatment for mitigate mice. Hence, may promote microglial responses represent an important pathophysiological process this its treatment.

参考文章(56)
Kuriko Kagitani-Shimono, Ikuko Mohri, Yasushi Fujitani, Kinuko Suzuki, Keiichi Ozono, Yoshihiro Urade, Masako Taniike, Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model Journal of Neuroinflammation. ,vol. 2, pp. 10- 10 ,(2005) , 10.1186/1742-2094-2-10
Pasqualino Ciappetta, Pietro Ivo D'Urso, Antonio Colamaria, Enrico Lauta, Antonia Cimmino, Oscar Fernando D'Urso, Roberta Rossi, Leonardo Resta, Giuseppe Ingravallo, Giant cell angiitis of the central nervous system with atypical presentation Neuropathology. ,vol. 30, pp. 434- 438 ,(2009) , 10.1111/J.1440-1789.2009.01073.X
C L Kincaid, A K Stalder, A Pagenstecher, I L Campbell, S D Shapiro, Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. American Journal of Pathology. ,vol. 152, pp. 729- 741 ,(1998)
Eun-Mee Kim, Onyou Hwang, Role of matrix metalloproteinase-3 in neurodegeneration. Journal of Neurochemistry. ,vol. 116, pp. 22- 32 ,(2011) , 10.1111/J.1471-4159.2010.07082.X
Y. Kondo, D. A. Wenger, V. Gallo, I. D. Duncan, Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 18670- 18675 ,(2005) , 10.1073/PNAS.0506473102
Franz-Xaver Gomis-R¨th, Klaus Maskos, Michael Betz, Andreas Bergner, Robert Huber, Ko Suzuki, Naoki Yoshida, Hideaki Nagase, Keith Brew, Gleb P. Bourenkov, Hans Bartunik, Wolfram Bode, Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature. ,vol. 389, pp. 77- 81 ,(1997) , 10.1038/37995
Stephen J. Crocker, Richard Milner, Ngan Pham-Mitchell, Iain L. Campbell, Cell and agonist‐specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells Journal of Neurochemistry. ,vol. 98, pp. 812- 823 ,(2006) , 10.1111/J.1471-4159.2006.03927.X